arsenic trioxidehttp://www.unboundmedicine.com/medline/ebm/research/arsenic_trioxideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma.http://www.unboundmedicine.com/medline/ebm/record/19927285/full_citation/Compound_heterozygous_mutation_with_a_novel_splice_donor_region_DNA_sequence_variant_in_the_succinate_dehydrogenase_subunit_B_gene_in_malignant_paraganglioma_Majumdar S, Friedrich CA, Koch CA, et al. 
Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma. [JOURNAL ARTICLE]
Pediatr Blood Cancer 2009 Nov 19.
Abstract | Full CitationSyk is a novel target of arsenic trioxide (ATO) and is involved in the toxic effect of ATO in human neutrophils.http://www.unboundmedicine.com/medline/ebm/record/19925860/full_citation/Syk_is_a_novel_target_of_arsenic_trioxide__ATO__and_is_involved_in_the_toxic_effect_of_ATO_in_human_neutrophils_Antoine F, Ennaciri J, Girard D 
Syk is a novel target of arsenic trioxide (ATO) and is involved in the toxic effect of ATO in human neutrophils. [JOURNAL ARTICLE]
Toxicol In Vitro 2009 Nov 16.
Abstract | Full Citation[Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis.]http://www.unboundmedicine.com/medline/ebm/record/19912733/full_citation/[Arsenic_trioxide_in_combination_with_all_trans_retinoic_acid_for_acute_promyelocytic_leukemia:_a_systematic_review_and_meta_analysis_]Xu SN, Chen JP, Liu JP, et al. 
[Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis.] [English Abstract, Journal Article]
Zhong Xi Yi Jie He Xue Bao 2009 Nov; 7(11):1024-34.
Abstract | Full Citation | Find Related Articles A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment.http://www.unboundmedicine.com/medline/ebm/record/19911123/full_citation/A_pharmacokinetic_and_safety_study_of_intravenous_arsenic_trioxide_in_adult_cancer_patients_with_renal_impairment_Sweeney CJ, Takimoto C, Wood L, et al. 
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2009 Nov 13.
Abstract | Full Citation | Find Related Articles Targeting PML-RAR{alpha} and Oncogenic Signaling Pathways by Chinese Herbal Mixture Tien-Hsien Liquid in Acute Promyelocytic Leukemia NB4 Cells.http://www.unboundmedicine.com/medline/ebm/record/19897545/full_citation/Targeting_PML_RAR{alpha}_and_Oncogenic_Signaling_Pathways_by_Chinese_Herbal_Mixture_Tien_Hsien_Liquid_in_Acute_Promyelocytic_Leukemia_NB4_Cells_Yao CJ, Yang CM, Chuang SE, et al. 
Targeting PML-RAR{alpha} and Oncogenic Signaling Pathways by Chinese Herbal Mixture Tien-Hsien Liquid in Acute Promyelocytic Leukemia NB4 Cells. [JOURNAL ARTICLE]
Evid Based Complement Alternat Med 2009 Nov 6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug.http://www.unboundmedicine.com/medline/ebm/record/19888912/full_citation/Evaluation_of_adverse_cardiac_effects_induced_by_arsenic_trioxide_a_potent_anti_APL_drug_Raghu KH, Yadav GK, Singh R, et al. 
Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug. [Journal Article]
J Environ Pathol Toxicol Oncol 2009; 28(3):241-52.
Abstract | Full CitationTRIM5alpha and TRIMCyp form apparent hexamers and their multimeric state is not affected by exposure to restriction-sensitive viruses or by treatment with pharmacological inhibitors.http://www.unboundmedicine.com/medline/ebm/record/19886997/full_citation/TRIM5alpha_and_TRIMCyp_form_apparent_hexamers_and_their_multimeric_state_is_not_affected_by_exposure_to_restriction_sensitive_viruses_or_by_treatment_with_pharmacological_inhibitors_Nepveu-Traversy ME, Berube J, Berthoux L 
TRIM5alpha and TRIMCyp form apparent hexamers and their multimeric state is not affected by exposure to restriction-sensitive viruses or by treatment with pharmacological inhibitors. [JOURNAL ARTICLE]
Retrovirology 2009 Nov 3; 6(1):100.
Abstract | Full Citation | Find Related Articles Evidence that endoplasmic reticulum (ER) stress and caspase-4 activation occur in human neutrophils.http://www.unboundmedicine.com/medline/ebm/record/19878647/full_citation/Evidence_that_endoplasmic_reticulum__ER__stress_and_caspase_4_activation_occur_in_human_neutrophils_Binet F, Chiasson S, Girard D 
Evidence that endoplasmic reticulum (ER) stress and caspase-4 activation occur in human neutrophils. [JOURNAL ARTICLE]
Biochem Biophys Res Commun 2009 Oct 27.
Abstract | Full Citation | Find Related Articles Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.http://www.unboundmedicine.com/medline/ebm/record/19850784/full_citation/Arsenic_trioxide_as_first_line_treatment_for_acute_promyelocytic_leukemia_Leu L, Mohassel L 
Arsenic trioxide as first-line treatment for acute promyelocytic leukemia. [Journal Article]
Am J Health Syst Pharm 2009 Nov 1; 66(21):1913-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles The Effect of MAPK Inhibitors on Arsenic Trioxide-treated Calu-6 Lung Cells in Relation to Cell Death, ROS and GSH Levels.http://www.unboundmedicine.com/medline/ebm/record/19846917/full_citation/The_Effect_of_MAPK_Inhibitors_on_Arsenic_Trioxide_treated_Calu_6_Lung_Cells_in_Relation_to_Cell_Death_ROS_and_GSH_Levels_Han YH, Moon HJ, You BR, et al. 
The Effect of MAPK Inhibitors on Arsenic Trioxide-treated Calu-6 Lung Cells in Relation to Cell Death, ROS and GSH Levels. [Journal Article]
Anticancer Res 2009 Oct; 29(10):3837-44.
Abstract | Full Citation | Find Related Articles